Platelet-tumor cell contacts and platelet-derived TGF-β synergistically activate the TGF-β/Smad and NFκB pathways in cancer cells enabling their transition to an invasive mesenchymal-like phenotype, thereby enhancing metastasis [20]. The gene discussed is NFKB1; the disease is cancer.